Effectiveness of methotrexate with step-down glucocorticoid remission induction ( COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Patrick Verschueren, Diederik De Cock*, Luk Corluy, Rik Joos, Christine Langenaken, Veerle Taelman, Frank Raeman, Isabelle Ravelingien, Klaas Vandevyvere, Jan Lenaerts, Elke Geens, Piet Geusens, Johan Vanhoof, Anne Durnez, Jan Remans, Bert Vander Cruyssen, Els Van Essche, An Sileghem, Griet De Brabanter, Johan JolySabrina Meyfroidt, Kristien Van der Elst, Rene Westhovens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)511-520
Number of pages10
JournalAnnals of the Rheumatic Diseases
Volume76
Issue number3
DOIs
Publication statusPublished - Mar 2017

Keywords

  • COMBINATION-TREATMENT STRATEGIES
  • TIGHT CONTROL
  • AMERICAN-COLLEGE
  • DMARD THERAPY
  • EARLY RA
  • MONOTHERAPY
  • RECOMMENDATIONS
  • SULFASALAZINE
  • MULTICENTER
  • MANAGEMENT

Cite this